Globe Life (NYSE:GL) CFO Thomas Peter Kalmbach Sells 25,650 Shares

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 25,650 shares of the firm’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the completion of the transaction, the chief financial officer directly owned 50,568 shares of the company’s stock, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24.
• On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total transaction of $1,864,128.83.
• On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total value of $1,792,315.80.
• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05.

Globe Life Stock Performance

GL opened at $179.69 on Thursday. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The firm has a market capitalization of $13.95 billion, a PE ratio of 11.93 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The business’s 50-day simple moving average is $170.49 and its 200 day simple moving average is $153.78.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period last year, the company posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, sell-side analysts expect that Globe Life Inc. will post 15.73 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Globe Life

Several large investors have recently modified their holdings of the stock. Hilton Head Capital Partners LLC acquired a new position in Globe Life in the 4th quarter valued at about $30,000. CYBER HORNET ETFs LLC acquired a new stake in Globe Life during the second quarter worth approximately $28,000. MUFG Securities EMEA plc bought a new stake in shares of Globe Life during the second quarter worth approximately $31,000. Torren Management LLC bought a new stake in shares of Globe Life during the fourth quarter worth approximately $37,000. Finally, AdvisorNet Financial Inc grew its position in shares of Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Piper Sandler raised their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Keefe, Bruyette & Woods dropped their price target on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research report on Friday, July 24th. Truist Financial increased their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Jefferies Financial Group lifted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. Finally, Wells Fargo & Company boosted their price objective on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $191.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.